J. Michael Straughn

At What Cost Does a Potential Survival Advantage of Bevacizumab Make Sense for the Primary Treatment of Ovarian Cancer? A Cost-Effectiveness Analysis

David E. Cohn, Kenneth H. Kim, Kimberly Resnick et al. · Journal of Clinical Oncology · 2011 · 172 citations

Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer

Rebecca C. Arend, Angelina I. Londoño-Joshi, Rajeev S. Samant et al. · Gynecologic Oncology · 2014 · 161 citations

Oncology, Medicine, Gynecology +8

A Prospective Blinded Evaluation of the Accuracy of Frozen Section for the Surgical Management of Endometrial Cancer

Ashley S. Case, Rodney P. Rocconi, J. Michael Straughn et al. · Obstetrics and Gynecology · 2006 · 159 citations

A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer

Caroline W. Cohen, Kevin R. Fontaine, Rebecca C. Arend et al. · Journal of Nutrition · 2018 · 151 citations · Full text

Obesity, Metabolic Syndrome, Nutrition +12

Conservative Management of Stage I Endometrial Carcinoma after Surgical Staging

J. Michael Straughn, Warner K. Huh, FJ Kelly et al. · Gynecologic Oncology · 2002 · 146 citations

Surgical Oncology, Gynecological Surgery, Medicine +5